Class I - Dangerous
Chemical contamination: emission of strong odor after package was opened.
💊
Prescription Drugs
💊 Drugs • 12,141 recalls
Class I - Dangerous
Chemical contamination: emission of strong odor after package was opened.
Class I - Dangerous
Chemical contamination: emission of strong odor after package was opened.
Class I - Dangerous
Chemical contamination: emission of strong odor after package was opened.
Class I - Dangerous
Failed USP Dissolution Test Requirements: Out-of-specification dissolution results at the 8 hour stability testing point.
Class I - Dangerous
Non-Sterility: Confirmed customer complaint of product contaminated with mold.
Class I - Dangerous
Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.
Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.
Teva Pharmaceuticals USA
Class I - Dangerous
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.
Class I - Dangerous
Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.
Class I - Dangerous
Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets by the manufacturer
Ethambutol Hydrochloride Tablets, USP, 100 mg, 100-count tablets per bottle, Rx only, Mfd. for: Versapharm Incorporated, Marietta, GA; Mfd. by: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724; NDC 61748-011-01.
West-ward Pharmaceutical
Class I - Dangerous
Subpotent Drug: Out Of Specification results for assay at the stability time-point of 24 months.
Aniracetam and Choline, Aniracetam 460 mg, Choline 76 mg, 180 capsules per bottler, non-Rx, distributed by BoostYourGrade, BoostYourGrade, LLC Orlando, FL
Palmer Natural Products
Class I - Dangerous
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Amoxicillin for Oral Suspension, 125mg/5mL, a) 80 mL (NDC 43598-222-80); b) 100mL, (NDC 43598-222-52); c)150 mL (NDC 43598-222-53) bottles, Rx only, Dist. By: Dr. REDDY'S Laboratories, Inc., Bridgewater, NJ 08807
Dr Reddys Laboratories Tennessee
Class I - Dangerous
Microbial Contamination of Non-Sterile Products: Suspensions made from these lots of Amoxicillin 125 mg/5 mL showed yeast and mold growth at the 14 day time point.
Brain Defogger, Piracetam 390mg Choline 104mg capsules, 100 count bottle, OTC, BoostYourGrade, LLC, Orlando, FL. .
Palmer Natural Products
Class I - Dangerous
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Oxiracetam & Choline , Oxiracetam 460mg Choline 110mg capsules a) 30 count bottle, b) 60 count bottle, c) 90 count bottle, OTC, BoostYourGrade, LLC, Orlando, FL. 32826
Palmer Natural Products
Class I - Dangerous
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Class I - Dangerous
Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrectly released without meeting product specifications. There is the potential for the solution to leak from the administrative port to the fill tube seal.
Aniracetam & Choline capsules, 430mg Aniracetam 88mg Choline, a) 30 count bottle b) 60 count bottle, c) 90 count, d) 180 count , OTC, BoostYourGrade, LLC Orlando, FL 32826
Palmer Natural Products
Class I - Dangerous
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Class I - Dangerous
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
BoostYourGrade.com, Piracetam 390mg Choline 104mg capsules, 250 count bottle, OYC, BoostYourGrade, LLC, Orlando, FL 32826
Palmer Natural Products
Class I - Dangerous
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96
Teva Pharmaceuticals USA
Class I - Dangerous
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.